Evidence map›Paper›PMID 29287683›Full record

ArticleVaccine2018

How close are countries of the WHO European Region to achieving the goal of vaccinating 75% of key risk groups against influenza? Results from national surveys on seasonal influenza vaccination programmes, 2008/2009 to 2014/2015.

Pernille Jorgensen, Jolita Mereckiene, Suzanne Cotter, Kari Johansen, Svetla Tsolova, Caroline Brown

Open access · hybridAbstract readHistorical Article
In one paragraph

Article in Vaccine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 144 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
144citing papers in PubMed, 3 pooled it
16.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

144 citing papers in PubMed, 3 syntheses or guidelines pooled it, 253 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Influenza vaccination in older people: a geriatrician's perspective.Aging clinical and experimental research · 2025
    Review
  19. Article
  20. Article

84 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Pernille JorgensenWHO Regional Office for Europe, UN City, Marmorvej 51, 2100 Copenhagen, Denmark. Electronic address: jorgensenp@who.int.
Jolita MereckieneHealth Protection Surveillance Centre, 25-27 Middle Gardiner Street, Dublin 1, Ireland.
Suzanne CotterHealth Protection Surveillance Centre, 25-27 Middle Gardiner Street, Dublin 1, Ireland.
Kari JohansenEuropean Centre for Disease Prevention and Control, Tomtebodavägen 11A, 171 65 Solna, Sweden.
Svetla TsolovaEuropean Centre for Disease Prevention and Control, Tomtebodavägen 11A, 171 65 Solna, Sweden.
Caroline BrownWHO Regional Office for Europe, UN City, Marmorvej 51, 2100 Copenhagen, Denmark.
European Centre for Disease Prevention and Control · SEHealth Protection Surveillance Centre · IEWorld Health Organization Regional Office for Europe · DK

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundInfluenza vaccination is recommended especially for persons at risk of complications. In 2003, the World Health Assembly urged Member States (MS) to increase vaccination coverage to 75% among older persons by 2010.

objectiveTo assess progress towards the 2010 vaccination goal and describe seasonal influenza vaccination recommendations in the World Health Organization (WHO) European Region.

methodsData on seasonal influenza vaccine recommendations, dose distribution, and target group coverage were obtained from two sources: European Union and European Economic Area MS data were extracted from influenza vaccination surveys covering seven seasons (2008/2009-2014/2015) published by the Vaccine European New Integrated Collaboration Effort and European Centre for Disease Prevention and Control. For the remaining WHO European MS, a separate survey on policies and uptake for all seasons (2008/2009-2014/2015) was distributed to national immunization programmes in 2015.

resultsData was available from 49 of 53 MS. All but two had a national influenza vaccination policy. High-income countries distributed considerably higher number of vaccines per capita (median; 139.2 per 1000 population) compared to lower-middle-income countries (median; 6.1 per 1000 population). Most countries recommended vaccination for older persons, individuals with chronic disease, healthcare workers, and pregnant women. Children were included in < 50% of national policies. Only one country reached 75% coverage in older persons (2014/2015), while a number of countries reported declining vaccination uptake. Coverage of target groups was overall low, but with large variations between countries. Vaccination coverage was not monitored for several groups.

conclusionsDespite policy recommendations, influenza vaccination uptake remains suboptimal. Low levels of vaccination is not only a missed opportunity for preventing influenza in vulnerable groups, but could negatively affect pandemic preparedness. Improved understanding of barriers to influenza vaccination is needed to increase uptake and reverse negative trends. Furthermore, implementation of vaccination coverage monitoring is critical for assessing performance and impact of the programmes.

Indexed as

Influenza VaccinesVaccinationVaccination CoverageAge FactorsEuropeEuropean UnionFemaleGeography, MedicalHealth PersonnelHealth PolicyHistory, 21st CenturyHumansImmunization ProgramsInfluenza, HumanMalePopulation SurveillanceInfluenza VaccinesImmunization programmesInfluenza vaccinesVaccination coverage

Identifiers

PMID29287683
PMCPMC5777640
OpenAlexW2779669322

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.